INTRODUCTION
Lipids are water-insoluble amphiphilic biomolecules; they are structurally diverse and generated by an intricate network of integrated metabolic pathways (1-6). Lipids are known to play key roles in the organization and function of biological membranes, energy homeostasis, signal transduction, vesicular trafficking, organelle biogenesis, and regulated cell death (5-14). The initial indications that lipids may also modulate the rate of cellular and organismal aging came from observations that longevity-extending mutations in the IGF-1 (insulin/ insulin-like growth factor 1) and TORC1 (target of rapamycin complex 1) signaling pathways elicit an increase in the concentration of storage lipids in the nematode Caenorhabditis elegans, the fruit fly Drosophila melanogaster and laboratory mice (reviewed in reference 15). In this review, we outline the important conceptual advance in our understanding of how lipid metabolism and transport control the pace of cellular aging in the yeast Saccharomyces cerevisiae. We critically evaluate several mechanisms underlying the essential roles of lipids in defining yeast longevity. We outline the most important unanswered questions and suggest directions for future research.
SOME LIPIDS ARE CRITICAL FOR LON-GEVITY OF THE YEAST SACCHAROMYCES CEREVISIAE

Sphingolipids define yeast replicative and chronological lifespans
In S. cerevisiae, the de novo synthesis of sphingolipids begins in the endoplasmic reticulum (ER) where the serine palmitoyltransferase (SPT) protein complex catalyzes a condensation of serine with palmitoyl-CoA to form 3-ketodihydrosphingosine ( Figure 1 ) (16-18). The activity of SPT in the ER can inhibited by the amino fatty acid antibiotic myriocin derived from certain thermophilic fungi (19, 20) . 3-ketodihydrosphingosine is transformed into dihydrosphingosine (DHS), which is then undergoes conversion into phytosphingosine (PHS) in the ER; DHS and PHS are sphingoid backbone bases of all sphingolipids ( Figure 1) (17, 21, 22 ). An acyl-CoA ester of hexacosanoic fatty acid having twenty six carbon atoms is then used as a fatty acid donor for the synthesis of dihydroceramide (dhCer) or phytoceramide (phytoCer) from DHS or PHS (respectively) in a reaction that is catalyzed by ceramide synthase (CerS) and confined to the ER (Figure 1 ) (22-27). The activity © 1996-2018 of the CerS protein complex in the ER can be inhibited by mycotoxins fumonisin B1 and australifungin (28, 29) . dhCer or phytoCer are transported from the ER to the Golgi apparatus by the coat protein complex II vesicle-mediated flow as well as by the Nvj2-facilitated transfer via the ER-Golgi membrane contact sites (Figure 1 ) (30-32). In the Golgi apparatus, a stepwise attachment of different polar groups converts dhCer and phytoCer into such complex sphingolipids as inositol-phosphorylceramide (IPC), mannosyl-inositolphosphorylceramide (MIPC) and mannosyl-di-inositolphosphorylceramide (M(IP) 2 C) ( Figure 1) (33, 34) . The Aur1/Kei1-dependent synthesis of IPC in the Golgi apparatus can be inhibited by aureobasidin A, an antifungal cyclic depsipeptide antibiotic (33, 35, 36) . A vesicular flow delivers these complex sphingolipids 3-ketodihydrosphingosine, dihydrosphingosine and phytosphingosine (DHS and PHS, respectively; two sphingoid backbone bases of all sphingolipids), acyl-CoA esters of very long-chain fatty acids (including the acyl-CoA ester of hexacosanoic fatty acid (C 26:0 FA-CoA)), as well as dihydroceramide and phytoceramide are all generated in the endoplasmic reticulum (ER). After being transported from the ER to the Golgi apparatus, phytoceramide undergoes conversion into complex sphingolipids, including inositol-phosphorylceramide (IPC), mannosyl-inositol-phosphorylceramide (MIPC) and mannosyl-di-inositol-phosphorylceramide (M(IP) 2 C). Following IPC, MIPC and M(IP) 2 C synthesis in the Golgi, these complex sphingolipids can be either sorted to the plasma membrane or used to regenerate ceramides in a reaction catalyzed by Isc1 in mitochondria. After DHS and PHS are synthesized in the ER, they can undergo phosphorylation in the cytosol. Such phosphorylation yields DHS-1-phosphate and PHS-1-phosphate (respectively), which can be further catabolized into ethanolamine-phosphate and aliphatic aldehydes having sixteen carbon atoms (C 16 aldehydes). Enzymes that catalyze anabolic or catabolic reactions of sphingolipid metabolism are displayed in green or red color, respectively. See text for more details. Abbreviations: Aur1, aureobasidin A resistance 1; Csg1 and Csg2, calcium-sensitive growth 1 and 2 (respectively); Csh1, CSG1/SUR1 homolog1; Dpl1, dihydrosphingosine phosphate lyase 1; ER, endoplasmic reticulum; FA, fatty acid; Ipt1, inositolphosphotransferase 1; IPC, inositol-phosphorylceramide; Isc1, inositol phosphosphingolipid phospholipase C 1; 3-KDHS, 3-ketodihydrosphingosine; Kei1, Kex2-cleavable protein essential for inositol-phosphorylceramide synthesis 1; Lac1, longevity-assurance gene cognate 1; Lag1, longevity assurance gene 1; Lip1, Lag1/Lac1 interacting protein 1; Lcb1, Lcb2, Lcb3, Lcb 4 and Lcb5, long-chain base proteins 1, 2, 3, 4 and 5 (respectively); MIPC, mannosyl-inositolphosphorylceramide; M(IP) 2 C, mannosyl-di-inositol-phosphorylceramide; Npr1, nitrogen permease reactivator 1; Orm1 and Orm2, orosomucoid 1 and 2 (respectively); PM, plasma membrane; Sac1, suppressor of actin 1; SPOTS, serine palmitoyltransferase, Orm1/2 and Sac1; Sit4, suppressor of initiation of transcription 4; Slm1/2, synthetic lethal with Mss4 protein 1 or 2; SPT, serine palmitoyltransferase; Sur2, suppressor 2 of Rvs161 and rvs167 mutations; Tsc3 and Tsc10, temperature-sensitive suppressors of Csg2 mutants 3 and 10; Ydc1, yeast dihydroceramidase 1; Ypc1, yeast phytoceramidase 1; Ysr3, yeast sphingolipid resistance 3. © 1996-2018 from the Golgi apparatus to the plasma membrane (PM) (Figure 1) (1, 37). After being synthesized in the Golgi apparatus, these complex sphingolipids can also be used to replenish the cellular pool of ceramides. Such replenishment occurs in mitochondria and is catalyzed by Isc1, an inositol phosphosphingolipid phospholipase C which is translocated from the ER to mitochondria during the post-diauxic growth phase (Figure 1) (38-40) . Following DHS and PHS synthesis in the ER, these sphingoid backbone bases of sphingolipids can be used not only for ceramide synthesis in the ER but also for phosphorylation in the cytosol (Figure 1) (37, 41) . The products of such phosphorylation, DHS-1-phosphate and PHS-1-phosphate (respectively), can be then converted into such non-sphingolipid molecules as ethanolaminephosphate and aliphatic aldehydes having sixteen carbon atoms (42).
There are two different ways to study aging of the budding yeast S. cerevisiae. The first way is to monitor the replicative mode of yeast aging, which is measured as the maximum number of daughter cells that a mother cell can produce before becoming senescent (43-45). It seems that yeast replicative aging mirrors aging of some dividing, mitotically active mammalian and human cells (such as lymphocytes) (43, 44, 46-49) as well as aging of non-dividing cells in certain post-mitotic tissues of laboratory roundworms and humans (49-51). The second way is to examine the chronological mode of yeast aging, which is monitored as the length of time during which a cell remains viable by preserving a reproductive (clonogenic) ability after cell growth and division have been arrested (47, 52-54). Chronological aging in yeast is believed to model aging of non-dividing, post-mitotic mammalian and human cells (such as neurons) (47, 52, 53, 55-59).
Growing evidence supports the notion that certain molecular species of long-chain sphingoid bases of sphingolipids, ceramides and/or more complex sphingolipids (which are formed from ceramides through the covalent attachment of certain polar head groups) may play essential roles in defining the rates of replicative or chronological aging in the yeast S. cerevisiae. Specifically, it has been demonstrated that some genetic or pharmacological interventions altering the concentrations of certain sphingolipid classes extend yeast replicative or chronological lifespan (RLS or CLS, respectively).
For example, a single-gene-deletion mutation eliminating the Lag1 subunit of CerS (Figure 1 ) extends yeast RLS (23) but not CLS (60). Of note, a single-gene-deletion mutation eliminating a different subunit of CerS, Lac1 (Figure 1 ), does not alter yeast RLS or CLS (61). Two alternative explanations for the essential mechanistic role of Lag1 in yeast RLS have been proposed, namely that 1) lack of Lag1 (but not lack of Lac1) elicits a change in the concentrations of sphingosine and/or ceramide species that are critical for longevity of replicatively aging yeast; or 2) Lag1 determines yeast RLS not because of its distinct effects on sphingosine and/or ceramide concentrations but because of its known physical and functional interactions with many proteins that do not interact with Lac1 and are not related to sphingolipid metabolism (62). The unique role of Lag1 in regulating longevity of replicatively aging yeast is underscored by the observations that both the lack of this subunit of CerS (23) and its moderate overexpression prolong yeast RLS (61), whereas its massive overexpression has an opposite effect on the RLS of S. cerevisiae (61). Thus, it is conceivable that the relative level of the Lag1 subunit of CerS exhibits a non-linear dose-response effect on the concentrations of some distinct sphingosine and/or ceramide species with the essential roles in yeast RLS but not in CLS. The identities of such critical species of sphingosine (DHS and/or PHS) and/or ceramide (dhCer and/or phytoCer) remain to be established, perhaps by measuring the concentrations of different sphingolipid metabolism intermediates in yeast mutant strains that exhibit a wide-range expression levels of Lag1 and have quite different RLS.
Single-gene-deletion mutations eliminating Ipt1 and/or Skn1, two inositolphosphotransferases involved in the synthesis of M(IP) 2 C from MIPC (63, 64) (Figure 1 ), have been shown to extend yeast CLS (60, 65). Each of these mutations causes an accumulation of excessive amounts of MIPC and impairs the synthesis of M(IP) 2 C, the most abundant and complex sphingolipid in S. cerevisiae (63, 64). These findings suggest that M(IP) 2 C may be an essential negative regulator of yeast CLS and/or MIPC may play an essential stimulatory role in regulating yeast CLS.
A single-gene-deletion mutation eliminating Isc1, an inositol phosphosphingolipid phospholipase C which hydrolyzes complex sphingolipids to produce ceramides (38-40) (Figure 1 ), has been shown to shorten yeast CLS (66). The most prominent effects of the isc1Δ mutation on cellular sphingolipids include a decline in the concentrations of different molecular species of DHS and a rise in the concentrations of dhCer and phytoCer having twenty six carbon atoms (67). The CLS-shortening effect of the isc1Δ mutation was likely due to its demonstrated abilities to lower mitochondrial respiration, diminish catalase A activity, stimulate cellular iron accumulation, intensify oxidative damage to cellular macromolecules, decrease cell resistance to oxidative stress, enhance programmed apoptotic cell death, and/or activate Hog1 (a mitogen activated protein kinase (MAPK) of the high osmotic glycerol (HOG) pathway) (66-68). Importantly, the abilities of the isc1Δ mutation to shorten yeast CLS, lessen mitochondrial respiration, weaken catalase © 1996-2018 A activity and decline cell resistance to oxidative stress can be partially suppressed by a single-genedeletion mutation that eliminates any of the following four proteins: 1) Sit4, a catalytic subunit of type 2A ceramide-activated protein phosphatase and a downstream effector in the TORC1-Sit4 branch of the nutrient and stress signaling TORC1 pathway (67); 2) Hog1 (68); 3) Tor1, a nutrient-sensing protein kinase component of TORC1, which regulates cell growth, metabolism, stress response and longevity in response to nutrient availability and cellular stresses (69); or 4) Sch9, a nutrient-sensing protein kinase and a downstream effector in the TORC1-Sch9 branch of the TORC1 pathway (69). It needs to be emphasized that both the TORC1-Sit4 and TORC1-Sch9 branches are modulated not only in response to nutrient availability but also in response to concentrations of certain sphingolipid species; some of these sphingolipid species are synthesized de novo while others are produced by the Isc1-driven hydrolysis of complex sphingolipids (17, 18, 37, 62, 70-73). Furthermore, the TORC1-Sit4 branch regulates some reactions of the de novo sphingosine and ceramide biosynthesis (74), whereas the TORC1-Sch9 branch controls the production of sphingosines, ceramides and complex sphingolipids both biosynthetically and hydrolytically (75). Moreover, the Sch9 protein component of the TORC1-Sch9 branch is required for the translocation of Isc1 from the ER to mitochondria during the post-diauxic growth phase (75). These findings support the notion that the TORC1-Sit4 and TORC1-Sch9 branches, as well as Hog1 and Isc1, are linked nodes of a signaling network that integrates nutrient and sphingolipid signaling to regulate longevity of chronologically aging yeast (37, 62, 69-75). A more detailed description of this signaling network is provided below in this section and schematically depicted in Figure 2 .
The identities of molecular species of mitochondrial membrane sphingolipids that may modulate information flow through the TORC1-Sit4/ TORC1-Sch9/Hog1/Isc1 signaling nodes remain to be established. These sphingolipid species may include DHS and PHS, two sphingoid backbone bases of sphingolipids whose concentrations in yeast are gradually increased with chronological age (76). Such age-related rise of DHS and PHS in mitochondrial membranes of chronologically aging yeast may shorten CLS by slowing mitochondrial fusion, eliciting mitochondrial fragmentation, lowering mitochondrial respiration and electrochemical membrane potential, compromising ATP synthesis in mitochondria, and lessening the number of mitochondrial DNA copies (76).
Another convincing evidence for the essential roles of sphingolipids in yeast chronological aging has been provided by the demonstration that yeast CLS can be extended by pharmacological and genetic interventions that weaken (but do not completely stop) metabolite flow through the pathway of de novo sphingolipid synthesis. Such weakening of metabolite flow through sphingolipid synthesis pathway was achieved via a partial inhibition of the initial, SPTdriven step of the pathway using 1) relatively low concentrations of myriocin, an inhibitor of SPT enzymatic activity (77) (Figure 1) ; or 2) the tetracyclinerepressible promoter cassette to lower transcription of genes encoding the Lcb1 or Lcb2 subunits of the SPT protein complex (77) (Figure 1 ). By eliciting a partial inhibition of SPT, both these CLS-extending interventions have been shown to decrease the concentrations of DHS, PHS, DHS-1-phosphate, PHS-1-phosphate and IPC (77) (Figure 1 ). Such decline in the abundance of sphingosine species and/or IPC is likely to be responsible for the observed abilities of both these interventions to lower protein kinase activities of Pkh1 (Pkb-activating kinase homolog protein 1) and Pkh2, two sphingolipid-activated protein kinases that phosphorylate a specific residue in the activation loop of the nutrient-sensing protein kinase Sch9 (77). Pkh1 and Pkh2 are likely stimulated by PHS (78). Although the Pkh1/2-Sch9 branch of a network that integrates nutrient and sphingolipid signaling is the primary target of both these interventions, myriocin treatment also elicits the following pro-longevity changes in other pathways possibly integrated into this network: 1) it weakens the pro-aging PKA (protein kinase A) pathway; 2) it attenuates the pro-aging TORC1 pathway; 3) it activates the anti-aging Snf1 (sucrose non-fermenting) pathway; and 4) it stimulates the antiaging ATG (autophagy) pathway (79). These effects of myriocin treatment on different nodes and hubs comprising the nutrient and sphingolipid signaling network are believed to be responsible for the global changes in transcription of numerous nuclear genes seen in myriocin-treated yeast (79). It is presently unclear which of the above effects of myriocin treatment on signaling and transcription are due to the decline in the abundance of sphingosine species and IPC that occurs in yeast exposed to myriocin (62). Some of these effects could be due to the abilities of certain sphingolipid species to act in minor quantities as signaling molecules that bind to specific protein components integrated into the nutrient and sphingolipid signaling network, whereas others could be caused by the abilities of bulk quantities of sphingolipids to influence general physical properties of cellular membranes and/or create functionally distinct membrane domains (62).
In sum, emergent evidence indicates that the metabolic pathway for the biosynthetic and hydrolytic production of sphingosines, ceramides and complex sphingolipids is integrated into an intricate network with certain nutrient-and sphingolipid-sensing signaling pathways. This network defines yeast CLS and is schematically depicted in Figure 2 . The nutrient and sphingolipid signaling network includes three hubs, © 1996-2018 Sit4, another component of this branch, can be inhibited by TORC1 and activated by phytoCer (37, 67, 73, 83, 84) (Figure 2A ). Orm1 and Orm2 can also be phosphorylated (and SPT inhibition can be relieved) via partially overlapping TORC2-Ypk1/2 and Pkh1/2-Ypk1/2 signaling branches; a common component of these branches, the protein kinase Ypk1/2, phosphorylates Orm1 and Orm2 at sites that differ from sites phosphorylated by the protein kinase Npr1 of the TORC1-Sit4-Npr1 branch (37, 73, 82-84) (Figure 2A ). Both the TORC2-Ypk1/2 and Pkh1/2-Ypk1/2 branches are modulated by sphingolipids. The TORC2-Ypk/2 branch of the TORC2 signaling pathway is activated if a decline in the abundance of complex sphingolipids increases tension of the PM; this allows the phosphatidylinositol-4,5-bisphosphate binding proteins Slm1 and Slm2 to move from the MCC (membrane compartment containing Can1)/ eisosome domain of the PM to the MCT (membrane compartment containing TORC2) area of the PM, where they activate Ypk1/2 phosphorylation by the PM-associated TORC2 complex (37, 73, 82, 85, 86) ( Figure 2A ). The Pkh1/2-Ypk1/2 branch is activated by PHS, a sphingoid base of sphingolipids which stimulates both protein components of this signaling branch (37, 78) ( Figure 2A ). The TORC1-Sit4-Npr1-, TORC2-Ypk1/2-and Pkh1/2-Ypk1/2-dependent phosphorylations of Orm1 and Orm2 can be offset (and SPT inhibition can be restored) by the complex between Cdc55 and Pph21/Pph22, a regulatory and catalytic subunits (respectively) of yeast protein phosphatase 2A (PP2A) (37, 73, 87) ( Figure 2A ). Altogether, these findings indicate that the SPT hub of the nutrient and sphingolipid signaling network is modulated by three feedback loops. One of these feedback loops acts in a negative manner (i.e. SPT is indirectly inhibited by complex sphingolipids), whereas two others are positive feedback loops (i.e. SPT is indirectly activated by PHS and phytoCer) ( Figure 2A ). It is conceivable that these three feedback loops orchestrate a delicate tuning of SPT activity in response to the availability of nutrients and the extent of cellular stress (which is exhibited in part as changes in sphingolipid concentrations), thus defining longevity of chronologically aging yeast.
Another hub of the nutrient and sphingolipid signaling network includes the CerS protein complex, ceramidases Ydc1 and Ypc1, and the sphinganine C4-hydroxylase Sur2 ( Figure 2B ). These proteins and protein complexes are involved in the synthesis of dhCer and phytoCer from DHS and PHS, hydrolysis of dhCer and phytoCer to DHS and PHS, and conversion of DHS into PHS (respectively) (Figure 1 ). At the CerS/ Ydc1/Ypc1/Sur2 hub, CerS is activated in response to phosphorylation at different sites by 1) Ypk1/2, a common component of partially overlapping TORC2-Ypk1/2 and Pkh1/2-Ypk1/2 signaling branches (88, 89); and 2) casein kinase 2 (CK2), a Ser/Thr protein kinase with many cellular functions (90, 91) ( Figure  2B ). The TORC2-Ypk1/2 branch is attenuated by complex sphingolipids, whereas both components of the Pkh1/2-Ypk1/2 branch are activated by PHS (37, 78, 73, 82, 85, 86) ( Figure 2B ). The TORC2-Ypk1/2 branch is also weakened by calcineurin, a Ca 2+ / calmodulin-regulated type 2B protein phosphatase (PP2B) which stimulates the dephosphorylation of CerS sites phosphorylated by Ypk1/2 (88, 89) ( Figure  2B ). Ceramidases Ydc1 and Ypc1 are components of the CerS/Ydc1/Ypc1/Sur2 hub whose abundance can be decreased if the nutrient-sensing protein kinase Sch9 represses transcription of the YDC1 and YPC1 genes (75) ( Figure 2B ). Sch9 is a common component of the partially overlapping TORC1-Sch9 and Pkh1/2-Sch9 signaling branches; it can be activated if concomitantly phosphorylated at different sites by nutrient-sensing TORC1 and PHS-dependent Pkh1/2 (77, 79, 82, 92-94) ( Figure 2B ). The Sur2 component of the CerS/Ydc1/Ypc1/Sur2 hub can be activated by Sit4, a catalytic subunit of PP2A which can be inhibited by nutrient-sensing TORC1 and stimulated by phytoCer (37, 67, 73, 74, 83, 84) ( Figure 2B ). Thus, the CerS/Ydc1/Ypc1/Sur2 hub of the nutrient and sphingolipid signaling network is under control of the following four feedback loops: 1) a positive feedback loop in which CerS is indirectly activated by PHS; 2) a negative feedback loop in which CerS is indirectly inhibited by complex sphingolipids; 3) a negative feedback loop in which Ydc1 and Ypc1 are indirectly inhibited by PHS; and 4) a positive feedback loop in which Sur2 is indirectly activated by phytoCer ( Figure  2B ). It is tempting to speculate that these four feedback loops allow to coordinate the synthesis and breakdown of DHS, PHS, dhCer and phytoCer in response to the intracellular nutrient and stress status, thereby being essential for regulating longevity of chronologically aging yeast.
The third hub of the nutrient and sphingolipid signaling network includes enzymes involved in the synthesis and hydrolysis of complex sphingolipids ( Figure 2C ). The synthesis of complex sphingolipids in the Golgi apparatus is activated by phosphorylated forms of the Orm1 and Orm2 proteins; a mechanism of such activation remains unknown (84) ( Figure 2C ). Orm1 and Orm2 are phosphorylated by the protein kinase Npr1 of the TORC1-Sit4-Npr1 signaling branch; the Sit4 component of this branch can be suppressed by nutrient-sensing TORC1 and can be stimulated by phytoCer (37, 74, 84) ( Figure 2C ). The hydrolysis of complex sphingolipids in mitochondria is catalyzed by Isc1, whose translocation from the ER to mitochondria during the post-diauxic growth phase requires the nutrient-sensing protein kinase Sch9 (75). The Sch9-driven stimulation of complex sphingolipids hydrolysis is under positive control of the TORC1-Sch9 and Pkh1/2-Sch9 signaling branches, as nutrient-sensing TORC1 and PHS-dependent Pkh1/2 can activate © 1996-2018 Sch9 by phosphorylating different sites of this protein (77, 79, 82, 92-94) ( Figure 2C ). Besides their essential roles in regulating the synthesis and hydrolysis of complex sphingolipids (as well as other reactions of sphingolipid metabolism; see Figures 2A and 2B), the TORC1-Sit4 and TORC1-Sch9 branches are nodes of a signaling subnetwork that modulates mitochondrial functionality in response to nutrient status and phytoCer concentration ( Figure 2C ). This signaling subnetwork integrates the TORC1-Sit4 and TORC1-Sch9 branches with Hog1 (a MAPK which is phosphorylated by Sch9) and Isc1, thereby coordinating sphingolipid metabolism and mitochondrial function and regulating longevity of chronologically aging yeast (37, 62, 69-75) ( Figure  2C ). Together, these findings indicate that the third hub of the nutrient and sphingolipid signaling network is controlled by a positive feedback loop which indirectly activates complex sphingolipid synthesis by phytoCer, as well as by a positive feedback loop which indirectly stimulates complex sphingolipid hydrolysis by PHS ( Figure 2C ). By coordinating complex sphingolipid metabolism and mitochondrial functionality in response to the intracellular nutrient and stress status, these feedback loops are likely to play essential role in regulating longevity of chronologically aging yeast.
Triacylglycerol metabolism is a longevity assurance process
Triacylglycerols (TAGs) are uncharged (and therefore called ″neutral″) lipids synthesized in the ER and then deposited in lipid droplets (LDs) (72, 95, 96). The hydrolytic degradation of TAGs stored in LDs can provide free fatty acids (FFAs) and diacylglycerols (DAGs) for the production of energy, synthesis of phospholipid and sphingolipid constituents of cellular membranes, and generation of some signaling lipids (7, 72, 95-99).
The metabolic pathways of TAG synthesis and degradation in yeast cells are well known (95, 96, 98, 99); they are schematically depicted in Figure 3 . The de novo synthesis of TAGs begins in the ER where two glycerol-3-phosphate/dihydroxyacetone phosphate (Gro-3-P/DHAP) acyltransferases, Sct1 and Gpt2, catalyze the formation of lysophosphatidic acid (LPA) or acyl-DHAP from fatty acyl-CoA esters (FA-CoAs) and Gro-3-P or DHAP, respectively (100, 101) ( Figure  3 ). FA-CoAs, which serve as co-substrates in these Sct1-and Gpt2-driven reactions, are synthesized de novo from acetyl-CoA by the cytosolic acetyl-CoA carboxylase Acc1 and FA synthase complex Fas1/ Fas2 (102-107) (Figure 3 ). LPA can also be formed from acyl-DHAP in an Ayr1-driven reduction reaction (108) (Figure 3 ). The LPA acyl-transferases Slc1, Slc4, Loa1 and Ale1 catalyze the conversion of LPA to PA in an acyl CoA-dependent reaction (109-113) ( Figure  3 ). PA can then be used as a substrate in two different reactions, each yielding a distinct precursor molecule for a biosynthetic pathway that contributes to TAG formation de novo. One of these reactions is catalyzed by the cytidine diphosphate (CDP)-DAG synthase Cds1; this reaction converts PA to CDP-DAG, which is then used for the synthesis of the phospholipids phosphatidylserine (PS), phosphatidylcholine (PC) and phosphatidylinositol in the ER and also of the phospholipid phosphatidylethanolamine (PE) in mitochondria ( The intensities of lipid fluxes via metabolic pathways for TAG synthesis and degradation in yeast cells are modulated by different mechanisms, controlled in space and time, and altered in response to certain changes in environmental, nutritional and developmental conditions. Indeed, many reactions of TAG synthesis and degradation are catalyzed by partially redundant enzymes that have different substrate specificities ( Figure 3) ; this may allow to modulate the cellular concentrations of TAGs, DAGs, phospholipids and FFAs under different internal and external conditions (95, 97-99). Also, some enzymes involved in TAG synthesis (i.e. Gpt2, Ayr1, Slc1, Loa1 and Dga1), TAG hydrolysis (i.e. Tgl1 and Yju3) and FFA reactivation (i.e. Faa1, Faa4 and Fat1) in yeast © 1996-2018 cells exhibit dual localization to the ER and LDs; this may also be used as a mechanism for adapting the anabolic and catabolic branches of TAG metabolism to certain changes in intracellular and extracellular conditions (72, 95, 98, 99). In addition, the ER and LDs form physical contacts and share lipid intermediates of TAG metabolism with many other cellular structures, including mitochondria, peroxisomes, vacuoles, the nucleus, the Golgi apparatus and the PM; this allows to maintain lipid homeostasis of the entire cell under different environmental, nutritional and developmental conditions (134-137, 140-149). Furthermore, TAG lipolysis supplies (while TAG synthesis removes) certain TAG metabolism intermediates that in yeast cells play essential roles in cell cycle progression and cytokinesis; these pathways of TAG metabolism 1) are controlled by the cyclin-dependent kinases Pho85-Pho80 and/or Cdc28 at two different cellcycle checkpoints, and 2) modulate the intracellular concentrations of lipid species that control cell-cycle progression activities of the phosphatase PP2A Pathways for the synthesis of phospholipids in the endoplasmic reticulum (ER) and mitochondria partially overlap with the anabolic branch of TAG (triacylglycerol) metabolism in the ER. The catabolic branch of TAG metabolism is confined to lipid droplets (LDs) and peroxisomes. Enzymes that catalyze anabolic or catabolic reactions of TAG metabolism are displayed in green or red color, respectively. See text for more details. Abbreviations: Acc1, acetyl-CoA carboxylase 1; Ale1, acyltransferase for lysophosphatidylethanolamine 1; App1, actin patch protein 1; Are1/2, acyl-coenzyme A: cholesterol acyl transferase-related enzymes 1 and 2; Ayr1, acyl-dihydroxyacetone-phosphate reductase 1; CDP, cytidine diphosphate; Cds1, CDPdiacylglycerol synthase 1; Cho1/2, choline requiring 1 and 2; DAG, diacylglycerol; Dga1, diacylglycerol acyltransferase 1; Dgk1, diacylglycerol kinase 1; Dpp1, diacylglycerol pyrophosphate phosphatase 1; DHAP, dihydroxyacetone phosphate; Faa1/4, fatty acid activation 1 and 2; FA-CoA, fatty acylCoA ester; Fas1/2, fatty acid synthetases 1 and 2; Fat1, fatty acid transporter 1; FFA, free fatty acid; Fox1/2/3, fatty acid oxidation 1, 2 and 3; Gpd1/2, glycerol-3-phosphate dehydrogenases 1 and 2; Gpt2, glycerol-3-phosphate acyltransferase; Gro, glycerol; Gro-3-P, glycerol-3-phosphate; OMM, outer mitochondrial membrane; IMM, inner mitochondrial membrane; Loa1, lysophosphatidic acid: oleoyl-CoA acyltransferase 1; Lpp1, lipid phosphate phosphatase 1; LPA, lysophosphatidic acid; Lro1, lecithin cholesterol acyl transferase related open reading frame 1; MAG, monoacylglycerol; Opi3, overproducer of inositol 3; PA, phosphatidic acid; Pah1, phosphatidic acid phosphohydrolase 1; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PS, phosphatidylserine; Psd1, phosphatidylserine decarboxylase 1; Sct1, suppressor of choline-transport mutants 1; Slc1/4, sphingolipid compensation 1 and 4; Tgl1/3/4/5, triglyceride lipases 1, 3, 4 and 5. © 1996-2018 Given that TAG metabolism in S. cerevisiae is spatially and temporally integrated into many vital cellular processes confined to different cellular compartments and controlled by some key signaling pathways in response to specific changes in intracellular and extracellular conditions, it is not surprising that TAG synthesis and degradation have been shown to define longevity of chronologically aging yeast. It seems that there are two different ways of delaying yeast chronological aging by differently altering the age-related dynamics of changes in intracellular TAG concentration. These two ways are described below.
One of these ways of aging delay has been discovered by studies of yeast cultured in a nutrientrich liquid medium initially containing 2% glucose (158, 159) . Under these so-called non-caloric restriction (non-CR) conditions yeast cells are not limited in the supply of calories (47, 160, 161) . In non-CR yeast, the intracellular concentration of TAGs is substantially increased during logarithmic (L), diauxic (D) and postdiauxic (PD) phases (161) . After entering stationary (ST) phase, yeast cells cultured under non-CR conditions gradually consume TAGs accumulated in LDs during the preceding L, D and PD phases of growth (161) . It has been found that in non-CR yeast 1) single-gene-deletion mutations eliminating the TAG lipases Tgl3 and/or Tgl4 increase TAG concentration and extend CLS; 2) a simultaneous lack of DAG acyltransferases Dga1 and Lro1 in the dga1Δlro1Δ mutant strain decreases TAG concentration and shortens CLS; and 3) the overexpression of the DAG acyltransferase Dga1 rises TAG concentration and prolongs CLS (158) . It was therefore concluded that an increase in the abundance of TAGs seen in tgl3Δ, tgl4Δ, tgl3Δtgl4Δ and Dga1 overexpressing cells under non-CR conditions is responsible for the extension of their CLS (158, 159) . A ″radical sink″ mechanism may underlie the ability of increased concentration of TAGs to serve as a longevity assurance factor in chronologically aging non-CR yeast (Figure 4) (159) . In this mechanism, an age-related accumulation of reactive oxygen species (ROS) in non-CR yeast elicits oxidative damage to different kinds of biological macromolecules, especially to unsaturated FFA known to be highly susceptible to such damage (159) . Genetic manipulations that increase an incorporation of unsaturated FFA into TAGs (i.e. the tgl3Δ and/or tgl4Δ mutations or Dga1 overexpression) may intensify the flow of these susceptible to oxidative damage unsaturated FFA into LDs, where TAGs are stored. This may decrease the abundance of unsaturated FFA in cellular membranes, thereby lowering the extent of an age-related oxidative damage to membrane lipids and proteins (and perhaps to water-soluble macromolecules, such as proteins, DNA and RNA) and extending the CLS of non-CR yeast (Figure 4 ) (159) . Moreover, because genetic manipulations that increase the incorporation of unsaturated FFA into TAGs may sequester the major target molecules of an age-related oxidative damage inside the hydrophobic core of LDs, this is expected to limit the distribution of oxidative damage to water-soluble molecules outside LDs and thus to prolong the CLS of non-CR yeast as well (Figure 4) (159) 
The other way of delaying yeast chronological aging by altering the age-related dynamics of TAGs has been discovered by studies of yeast placed on a CR diet; this diet was imposed by culturing S. cerevisiae in a nutrient-rich liquid medium initially containing 0.2.% or 0.5.% glucose (161, 162) . CR is a dietary intervention that delays aging not only in yeast (47, 58, 161) but also in multicellular eukaryotes across phyla (163) (164) (165) (166) (167) . In yeast cultured under CR conditions, the intracellular concentration of TAGs is increased during L and D phases to reach a significantly lower steadystate level than that in yeast cultured under non-CR conditions (161) . CR yeast cells completely consume TAGs during the subsequent PD phase, unlike non-CR yeast cells that maintain a relatively high concentration of TAGs through the entire CLS (161) . Yeast cells cultured under non-CR conditions (but not yeast cells cultured under CR conditions) amass ethanol (131, 161) . This product of glucose fermentation has been shown to decrease yeast CLS (168), however a mechanism by which ethanol shortens longevity of chronologically aging yeast remains unknown. Ethanol accumulated by yeast cells cultured under non-CR conditions has been shown to suppress the synthesis of Fox1, Fox2 and Fox3, all of which are the core enzymes of peroxisomal beta-oxidation of FFAs (169, 170) . Because of the resulting low efficiency of FFA oxidation in peroxisomes of prematurely aging non-CR yeast cells, they accumulate FFAs (161). Moreover, it has been shown that 1) a close physical association of peroxisomes with LDs promotes the lipolytic degradation of TAGs within LDs, thus providing bulk quantities of FFAs for beta-oxidation in yeast peroxisomes (130, 131, 135, 136) ; and 2) lack of peroxisomal Fox1, Fox2 or Fox3 in the fox1Δ, fox2Δ or fox3Δ mutant strain elicits an accumulation © 1996-2018 of electron-dense arrays of FFAs (which are called ″gnarls″), as well as a deposition of bulk quantities of TAGs, within yeast LDs (130, 135, 136) . Based on all these findings, a mechanism has been proposed for how a CR diet may extend yeast CLS by altering the spatiotemporal dynamics of TAG synthesis in the ER, TAG lipolysis in LDs and beta-oxidation of TAGderived FFAs in peroxisomes (10, 131, 161, [171] [172] [173] . This mechanism is schematically depicted in Figure 5 . 
Some mitochondrial membrane phospholipids define yeast chronological lifespan
A high-throughput chemical genetic screen for low molecular weight chemical compounds capable (162) . Yeast cells do not produce LCA or other bile acids, all of which are synthesized and released into an ecosystem by animals and humans (174) (175) (176) (177) . If LCA is added exogenously to yeast cultured in a liquid medium, this highly hydrophobic bile acid enters the yeast cell, is delivered to mitochondria, accumulates mainly in the inner mitochondrial membrane (IMM) and also associates with the outer mitochondrial membrane (OMM) (178). A body of evidence supports the notion that LCA slows down yeast chronological aging because it instigates specific changes in the concentrations of mitochondrial membrane phospholipids (178-183). This evidence has recently been thoroughly discussed (184) (185) (186) (187) (188) . We therefore briefly summarize below the data confirming that certain LCA-dependent changes in mitochondrial membrane phospholipids play essential roles in the ability of LCA to extend yeast CLS. These data are integrated into a model presented in Figure 6 .
After being sorted to a double membrane delimiting mitochondria, LCA elicits three major changes in the abundance and composition of mitochondrial membrane phospholipids. These major changes are depicted in Figure 6 and outlined beneath.
First change: LCA significantly increases the phospholipid/protein ratio of mitochondrial membranes; this rise in the abundance of all membrane phospholipid classes in mitochondria causes a substantial enlargement of these organelles (178) (Figure 6 ).
Second change: LCA considerably augments the relative concentration of PA, likely by activating its transfer from the ER to the OMM via mitochondria- Figure 6 . Exogenously added lithocholic bile acid (LCA) enters the yeast cell, accumulates in a double membrane delimiting mitochondria, and elicits major changes in the abundance and composition of mitochondrial membrane phospholipids. These changes in mitochondrial membrane phospholipids initiate a cascade of downstream events that gradually develop an anti-aging cellular pattern, thus extending longevity of chronologically aging yeast. See text for more details. Abbreviations: CDP-DAG, cytidine diphosphate-diacylglycerol; Cl, cardiolipin; ER, endoplasmic reticulum; OMM, outer mitochondrial membrane; IMM, inner mitochondrial membrane; IMS, intermembrane space; MLCL, monolysocardiolipin; PA, phosphatidic acid; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PG, phosphatidylglycerol; PS, phosphatidylserine; PGP, phosphatidylglycerol-phosphate ER contact sites and the ensuing movement of PA from the OMM via the intermembrane space (IMS) to the IMM (178, 183). PA is a so-called ″fusogenic″ lipid class known to stimulate a fusion of two or more small mitochondria into a single mitochondrion (182) . This LCA-driven increase in the relative concentration of PA causes a substantial decline in the number of mitochondria (178) (Figure 6 ).
Third change: LCA differently affects the relative concentrations of different phospholipid classes as follows: a) it causes a rise in PS, phosphatidylglycerol (PG) and PC; and b) it causes a decline in PE, cardiolipin (CL) and monolysocardiolipin (MLCL) (178, 183) (Figure 6 ). These effects of LCA are believed to be instigated by an LCA-dependent attenuation of Psd1 and Crd1, which catalyze the conversion of PS into PE and of PG into CL (respectively) (178, 183) (Figure 6 ). These LCA-driven changes in different phospholipids not only decrease the relative concentrations of the non-bilayer forming classes of phospholipids but also increase the relative concentrations of the bilayer forming classes of phospholipids (178, 183) ( Figure  6 ). The non-bilayer forming classes of phospholipids are known to enhance membrane curving for the IMM, whereas the bilayer forming classes of phospholipids have the opposite effect on IMM curving (178, [189] [190] [191] [192] . Because LCA elicits these divergent effects on the non-bilayer forming and bilayer forming classes of phospholipids, many cristae in mitochondria of yeast treated with LCA are disconnected from the IMM and amass within mitochondrial matrix as flat bilayers (178, 184, 186, 188) (Figure 6 ). Moreover, because LCA increases the phospholipid/protein ratio of mitochondrial membranes (see above), this bile acid also rises the abundance of such disconnected cristae inside mitochondria (178, 184, 186, 188) (Figure 6 ).
Taken together, these data indicate that the LCA-driven changes in mitochondrial membrane phospholipids play a causal role in enlarging mitochondria, lessening mitochondrial number, and increasing the abundance of mitochondrial cristae that are disconnected from the IMM and accumulate within mitochondrial matrix as flat bilayers (178, 184, 186, 188) (Figure 6 ).
The above changes in the abundance and morphology of mitochondria in LCA-treated yeast lead to significant changes in the concentrations of many mitochondrial proteins; these mitochondrial proteins have been implicated in such longevitydefining processes as the tricarboxylic acid cycle, glyoxylate cycle, electron transport chain, amino acid synthesis, heme synthesis and attachment, iron-sulfur clusters synthesis and assembly, NADPH synthesis, ROS detoxification, protein import and folding, stress response and protection, mitochondrial division, mitochondrial DNA replication and maintenance, and synthesis and translation of mitochondrial RNA (181, 183) (Figure 6 ). The LCA-driven changes in mitochondrial proteome of LCA-treated yeast alter the age-related chronology of several longevity-defining mitochondrial processes, including mitochondrial respiration, membrane potential preservation, ROS homeostasis maintenance and ATP synthesis (178, 183) (Figure 6 ). These LCA-dependent alterations in mitochondrial functionality allow mitochondria to operate as signaling platforms that a) orchestrate a longevity-extending transcriptional program for many nuclear genes that are controlled by a discrete set of ten transcriptional factors, thus altering the entire cellular proteome; b) promote changes in the lipidomes of cellular organelles other than mitochondria; and c) elicit changes in the concentrations of certain watersoluble metabolites located outside of mitochondria (178, 181, 183, 188) (Figure 6 ).
In sum, the LCA-driven changes in mitochondrial membrane phospholipids trigger a cascade of downstream events that gradually lead to the development of a cellular pattern extending yeast CLS. In the future it would be interesting to investigate mechanisms through which LCA-dependent changes in mitochondrial functionality prompt changes in membrane lipidomes and water-soluble metabolomes outside of mitochondria. Another challenge is to assess the timetable of events that, in response to LCA-driven changes in mitochondrial membrane phospholipids, lead to the development of a pro-longevity pattern of the entire yeast cell.
SUMMARY AND PERSPECTIVE
Recent studies have provided an important conceptual advance in our understanding of the mechanisms that underlie the vital roles of sphingolipids, TAGs and mitochondrial membrane phospholipids in controlling the pace of cellular aging in the yeast S. cerevisiae. The essential mechanistic role of lipid metabolism and transport in defining longevity of this unicellular eukaryote further supports the notion that some aspects of the maintenance of lipid homeostasis are essential for healthy aging in evolutionarily distant organisms. These eukaryotic organisms include not only laboratory strains of budding yeast, roundworms (15, , fruit flies (214) (215) (216) (217) (218) (219) (220) (221) (222) (223) and mammals (208, (224) (225) (226) (227) (228) (229) (230) (231) (232) (233) (234) (235) (236) (237) (238) (239) (240) (241) , but also humans (208, (232) (233) (234) (235) (241) (242) (243) (244) (245) (246) . The major challenge now is to get a greater insight into the mechanisms through which lipid metabolism and transport define lifespan and healthspan in multicellular model organisms and humans.
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